Design, Synthesis and Structure-Activity Relationship Optimization of Lycorine Derivatives for HCV Inhibition
Citations Over TimeTop 21% of 2015 papers
Abstract
Lycorine is reported to be a multifunctional compound. We previously showed that lycorine is an HCV inhibitor with strong activity. Further research on the antivirus mechanism indicated that lycorine does not affect the enzymes that are indispensable to HCV replication but suppresses the expression of Hsc70 in the host cell to limit HCV replication. However, due to the cytotoxicity and apoptosis induction of lycorine, lycorine is unsafe to be a anti-HCV agent for clinical application. As a result of increasing interest, its structure was optimized for the first time and a novel series of lycorine derivatives was synthesized, all of which lost their cytotoxicity to different degrees. Structure-activity analysis of these compounds revealed that disubstitution on the free hydroxyl groups at C1 and C2 and/or degradation of the benzodioxole group would markedly reduce the cytotoxicity. Furthermore, an α, β-unsaturated ketone would improve the HCV inhibitory activity of lycorine. The C3-C4 double bond is crucial to the anti-HCV activity because hydrogenation of this double bond clearly weakened HCV inhibition.
Related Papers
- → Lycorine and its Derivatives for Anticancer Drug Design(2010)134 cited
- → Design, Synthesis and Structure-Activity Relationship Optimization of Lycorine Derivatives for HCV Inhibition(2015)45 cited
- → Synthesis of the amaryllidaceae alkaloid, lycorine(1975)27 cited
- Inhibition of galactonolactone dehydrogenase activity by lycorine.(1996)
- → Distribution of Lycorine inSternbergia luteaKerGawl(1980)3 cited